GHRH agonist MR-409 protects β-cells from streptozotocin-induced diabetes.
Summary withdrawn
TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.
